<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Results in 
 <xref rid="fig0025" ref-type="fig" class="xref">Fig. 5</xref>(A–B) showed that the EOCL (50–200 mg/kg) and diazepam (1 mg/kg) caused significant (p &lt; 0.05–0.01) reduction in sleep latency (SL), and caused significant (p &lt; 0.05–0.01) increase in ketamine-induced total sleeping time (TST), indicating sedative effect 
 <xref rid="bib0105" ref-type="bibr" class="xref">[21]</xref>, 
 <xref rid="bib0110" ref-type="bibr" class="xref">[22]</xref>. Ketamine is known to act primarily in the thalamus and limbic systems acting as a non-competitive antagonist of 
 <italic class="italic">N</italic>-methyl-
 <italic class="italic">D-</italic>aspartate receptor 
 <italic class="italic">(N</italic>M
 <italic class="italic">D</italic>A
 <italic class="italic">)</italic> receptor. Thus the EOCD may be mediating its sedative effect through augmentation of the inhibitory activity on the NMDA receptors in addition to general CNS depression. 
 <italic class="italic">Curcuma longa</italic> is a component of herbal preparations used in the treatment of fever and mental disorders in Southwest Nigeria thus giving an insight into the rationale for its use in this region.
</p>
